---
schema_version: "secwatch.filing_event.v1"
accession: "0001689548-26-000056"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2026-06-12T20:46:23+00:00"
generated_at: "2026-06-12T20:56:44.341654+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders elect three Class III directors, ratify EY, approve say-on-pay

## Summary
- Gregory Norden, Marcio Souza, William Young elected Class III directors with 24.6M, 24.8M, and 21.3M votes for, respectively.
- Ratification of Ernst & Young as independent auditor for 2026 approved: 26.7M votes for, 39k against.
- Non-binding advisory vote on executive compensation approved: 24.1M for, 0.8M against.
- No other matters were submitted to stockholders at the 2026 annual meeting.

## SEC filing metadata
- accession: 0001689548-26-000056
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2026-06-12T20:46:23+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000056/0001689548-26-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000056/prax-20260610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001689548-26-000056
- JSON: https://secwatch.observer/filing/0001689548-26-000056.json
- Plain text: https://secwatch.observer/filing/0001689548-26-000056.txt

## Key facts
- Shareholder Votes
  Praxis Precision Medicines, Inc. shareholders approved Election of Class III Directors at the 2026-06-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The Company’s stockholders elected Gregory Norden, Marcio Souza and William Young to serve as Class III members of the Board of Directors of the Company until the Company’s 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal, with the votes cast as follows: Class III Director Nominees Votes For Votes Withheld Broker Non-Vote Gregory Norden 24,597,327 310,937 1,815,967 Marcio Souza 24,771,396 136,868 1,815,967 William Young 21,293,535 3,614,729 1,815,967
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000056/0001689548-26-000056-index.htm
- Shareholder Votes
  Praxis Precision Medicines, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-10 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 24,054,017 824,318 29,929 1,815,967
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000056/0001689548-26-000056-index.htm
- Shareholder Votes
  Praxis Precision Medicines, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm at the 2026-06-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 26,667,376 39,285 17,570 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000056/0001689548-26-000056-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.